SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-15-000387
Filing Date
2015-02-06
Accepted
2015-02-06 16:29:46
Documents
7
Period of Report
2015-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_020515.htm 8-K 20352
2 UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 224752
3 OPINION LETTER ex5-1.htm EX-5.1 13027
4 PRESS RELEASE ex99-1.htm EX-99.1 10380
5 GRAPHIC image_001.gif GRAPHIC 4280
6 GRAPHIC image_001.jpg GRAPHIC 11859
7 GRAPHIC image_004.jpg GRAPHIC 4032
  Complete submission text file 0001387131-15-000387.txt   298076
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 15584964
SIC: 2834 Pharmaceutical Preparations